Beijing Minhai Biotechnology Co., Ltd

A pharmaceutical company specializing in vaccine development and manufacturing, with a portfolio including 13-valent and 23-valent pneumococcal conjugate/polysaccharide vaccines, hepatitis B vaccine, varicella vaccine, rabies vaccine, DTaP-Hib, DTaP, pentavalent vaccine, IPV vaccine, TT vaccine, MMR vaccine and quadrivalent influenza vaccine.